Covered recipient · General Payments record
TIFFANY GRAY MOON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2023–2024
$2,818.49
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $453.46 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $125.00 | 1 |
| ABBVIE INC. | $80.90 | 4 |
| Organon LLC | $77.69 | 4 |
| Lilly USA, LLC | $55.84 | 3 |
| Novo Nordisk AS | $45.23 | 2 |
| PFIZER INC. | $32.05 | 2 |
| Exeltis, USA Inc. | $18.97 | 1 |
| Astellas Pharma US Inc | $17.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.86 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107683947 | CMS |
| ABBVIE INC. | $16.65 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107683949 | CMS |
| ABBVIE INC. | $14.27 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107683951 | CMS |
| ABBVIE INC. | $20.12 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107683953 | CMS |
| Amgen Inc. | $125.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117331532 | CMS |
| Astellas Pharma US Inc | $17.78 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139473226 | CMS |
| Exeltis, USA Inc. | $18.97 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150016731 | CMS |
| Lilly USA, LLC | $22.13 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135972384 | CMS |
| Lilly USA, LLC | $19.74 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135982325 | CMS |
| Lilly USA, LLC | $13.97 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135990278 | CMS |
| Novo Nordisk Inc | $23.51 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100317232 | CMS |
| Novo Nordisk Inc | $21.72 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100540332 | CMS |
| Organon Llc | $16.99 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282684 | CMS |
| Organon Llc | $21.05 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282680 | CMS |
| Organon Llc | $22.62 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136189114 | CMS |
| Organon Llc | $17.03 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136189112 | CMS |
| PFIZER INC. | $15.67 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131594985 | CMS |
| PFIZER INC. | $16.38 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131823686 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.